Liquid crystalline pluronic 105 pharmacogels as drug delivery systems: Preparation, characterization, and in vitro transdermal release

Journal of Drug Targeting

Volumn 18, Issue 5, 2010, Pages 404-411

  Muzzalupo, Rita ^a   Tavano, Lorena ^a   Nicoletta, Fiore Pasquale ^a   Trombino, Sonia ^a   Cassano, Roberta ^a   Picci, Nevio ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

In vitro percutaneous permeation studies; Lyotropic liquid crystals; Pluronic

Indexed keywords

ALPHA TOCOPHEROL; DICLOFENAC; PARACETAMOL; PLURONIC P105; POLOXAMER; PROPRANOLOL; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL TISSUE; ARTICLE; DEUTERON NUCLEAR MAGNETIC RESONANCE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STRUCTURE; GASTROINTESTINAL TOXICITY; HYDROPHILICITY; IN VITRO STUDY; LIQUID CRYSTAL; MEMBRANE PERMEABILITY; MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STOMACH ULCER; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; DRUG DELIVERY SYSTEMS; MAGNETIC RESONANCE SPECTROSCOPY; POLOXAMER;

EID: 77952229467     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903494211     Document Type: Article

References (36)

1. Alexandridis P, Holzwarth JF. (1997). Differential scanning calorimetry investigation of the effect of salts on aqueous solution properties of an amphiphilic block copolymer (Poloxamer). Langmuir, 13: 6074.
2. Alexandridis P, Olsson U, Lindman B (1995). Self-assembly of amphiphilic block copolymers: the (EO)13(PO)30(EO)13-water-pxylene system. Macromolecules, 28: 7700.
3. Alexandridis P, Zhou D, Khan A. (1996). Lyotropic liquid crystallinity in amphiphilic block copolymers: temperature effects on phase behavior and structure for poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) copolymers of different composition. Langmuir, 12: 2690.
4. Attwood D, Florence AT. (1982). Surfactant Systems, their Chemistry, Pharmacy and Biology. Biological Implication of Surfactant Presence in Formulations. London: Chapman & Hall.
5. Barry B, Williams A. (2003). Penetration enhancers. Adv Drug Deliv Rev, 56: 603.
6. Bender J, Ericson MB, Merclin N, Iani V, Rosén A, Engström S, Moan J. (2005). Lipid cubic phases for improved topical drug delivery in photodynamic therapy. J Control Release, 106: 350-360.
7. Cevc G, Blume G. (2001). New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim Biophys Acta, 1514: 191-205.
8. Chapman D. (1991). Lyotropic mesophase in biological systems. In Bahadur B, ed., Liquid Crystals Applications and Uses (p. 186). Singapore: World Scientific.
9. Cooper E, Berner B. (1987). Penetration enhancers. In Kydonieus AF, Berner B. eds. Transdermal Delivery of Drugs (p. 57, vol. 3). Boca Raton: CRC Press.
10. Dayan N, Touitou E. (2000). Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials, 21: 1879-1885.
11. Demus D, Richther L. (1978). Textures of Liquid Crystals. VEB Duutscher Verlag fur Grundstoffindustrie, Leipzig.
12. Geraghty PB, Attwood D, Collett JH, Dandiker Y. (1996). The in vitro release of some antimuscarinic drugs from monoolein/water lyotropic liquid crystalline gels. Pharm Res, 13: 1265-1271.
13. Gooris GS, Bouwstra JA. (2007). Infrared spectroscopic study of stratum corneum model membranes prepared from human ceramides, cholesterol, and fatty acids. Biophys J, 92: 2785-2795.
14. Ivanova R, Lindman B, Alexandridis P. (2000). Effect of glycols on the self-assembly of amphiphilic block copolymers in water. I. Phase diagrams and structure identification, Langmuir 16 3660.
15. Juhasz J, Lenaerts V, Raymond P, Ong H. (1989). Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels. Biomaterials, 10: 265-268.
16. Kigasawa K, Kajimoto K, Watanabe M, Kanamura K, Saito A, Kogure K. (2009). In vivo transdermal delivery of diclofenac by ion-exchange iontophoresis with geraniol. Biol Pharm Bull, 32: 684-687.
17. Klausner RD, Kleinfeld AM, Hoover RL, Karnovsky MJ. (1980). Lipid domains in membranes. Evidence derived from structural perturbations induced by free fatty acids and lifetime heterogeneity analysis. J Biol Chem, 255: 1286-1295.
18. Kossena GA, Charman WN, Boyd BJ, Porter CJ. (2004). A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs. J Control Release, 99: 217-229.
19. Lupo MP. (2001). Antioxidants and vitamins in cosmetics. Clin Dermatol, 19: 157.
20. Merclin N, Bender J, Sparr E, Guy RH, Ehrsson H, Engström S. (2004). Transdermal delivery from a lipid sponge phase-iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. J Control Release, 100: 191-198.
21. Miyazaki S, Kubo W, Itoh K, Konno Y, Fujiwara M, Dairaku M, Togashi M, Mikami R, Attwood D. (2005). The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol. Int J Pharm, 297: 38-49. (Pubitemid 40720264)
22. Muzzalupo R, Tavano L, Trombino S, Cassano R, Picci N. (2009). Lyotropic liquid crystals for topical delivery system. In Li S, ed. Current Focus on Colloids and Surfaces (pp. 295-312). Kerala, India: Transworld Research Network.
23. Ortiz A, Gómez-Fernández JC. (1987). A differential scanning calorimetry study of the interaction of free fatty acids with phospholipid membranes. Chem Phys Lipids, 45: 75-91.
24. Rao PR, Reddy MN, Ramakrishna S, Diwan PV. (2003). Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits. Eur J Pharm Biopharm, 56: 81-85.
25. Rowat AC, Kitson N, Thewalt JL. (2006). Interactions of oleic acid and model stratum corneum membranes as seen by 2H NMR. Int J Pharm, 307: 225-231.
26. Smith EW, Maibach HI. (1995). Percutaneous Penetration Enhancers. New York: CRC Press.
27. Spicer P. (2004). In Nalwa H, ed. Encyclopedia of Nanoscience and Nanotechnology (p. 881). Marcel Dekker, USA.
28. Suzuki T, Takei H, Yamazaki S. (1989). Formation of fine three-phase emulsions by the liquid crystal emulsification method with arginine-branched monoalkyl phosphate. J Colloid Interface Sci, 129: 491.
29. Svensson B, Alexandridis P, Olsson U. (1998). Self-Assembly of a poly(ethylene oxide)-poly(propylene oxide) block copolymer (Pluronic P104, (EO)27(PO)61(EO)27) in the presence of water and xylene. J Phys Chem B, 102: 7541.
30. Svensson M, Alexandridis P, Linse P. (1999). Modelling of the phase behaviour in ternary triblock copolymer-water-oil systems. Macromolecules, 32: 5435.
31. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. (1996). Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res, 13: 896-901.
32. Turchiello RF, Vena FC, Maillard P, Souza CS, Bentley MV, Tedesco AC. (2003). Cubic phase gel as a drug delivery system for topical application of 5-ALA, its ester derivatives and m-THPC in photodynamic therapy (PDT). J Photochem Photobiol B, Biol, 70: 1-6.
33. Valjakka-Koskela R, Kirjavainen M, Mönkkönen J, Urtti A, Kiesvaara J. (1998). Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. 175: 225.
34. Vyas SP, Jaitely V, Kanaujia P. (1997). Self-assessing supramolecular biovectors: a new dimension in novel drug delivery systems. Pharmazie, 52: 259-267.
35. Yang B, Armitage B, Marder S. (2004). Cubic liquid-crystalline nanoparticles. Angew. Chem. Int. Ed., 43: 4402.
36. Ziegenmeyer J. (1982). The influence of the vehicle on the absorption and permeation of drugs. In Brandau R, Lippold BH. eds. Dermal and Transdermal Absorption (p. 73). Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.